New Pre-Filled Syringe for Lanreotide Tops SPT Week in Review

5. T-Cell Therapy Approach Shows Potential as Cure for Chronic Hepatitis B Virus

Receptor-modified T cells successfully controlled chronic hepatitis B virus, showing promise as a potential cure for the disease. Read more.

4. Dupilumab Approved for Chronic Rhinosinusitis with Nasal Polyps

Dupilumab (Dupixent) is the first biologic medicine approved for inadequately controlled chronic rhinosinusitis with nasal polyposis. Read more.

3. Audit Suggests PBM Drug Pricing Practices May Lead to Higher Health Care Costs

An independent review of pharmacy benefit managers (PBMs) in Ohio indicates that PBM pricing practices likely contribute to rising health care costs. Read more.
2. FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer

The supplemental New Drug Application supports the expansion of niraparib’s indication as a late-line therapeutic option for patients with ovarian cancer. Read more.
1. FDA OKs New Pre-Filled Syringe for Lanreotide

The new syringe is designed to improve the subcutaneous administration of lanreotide (Somatuline Depot, Ipsen Biopharmaceuticals). Read more.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Top news of the week from Specialty Pharmacy Times.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Top news of the week from Specialty Pharmacy Times.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.